The President Muhammadu Buhari has approved the appointment of Dr. Ifedayo Morayo Adetifa as the new Director-General of the Nigeria Centre for Disease Control.
According to a statement issued by the Senior Special Assistant to the President (Media & Publicity), Garba Shehu on Monday, Dr. Adetifa is to replace Dr. Chikwe Ihekweazu who was recently appointed an assistant director-general of the World Health Organisation.
According to the statement, the president also approved the setting up of a Health Sector Reform Committee.
The committee, headed by Vice President, Yemi Osinbajo, as chairman, is expected to commence the development and implementation of a programme for Nigeria in collaboration with the state governments and the Federal Capital Territory administration.
The statement reads: in part: “President Buhari has approved the appointment of Dr. Ifedayo Morayo Adetifa as the new Director-General of the Nigeria Centre for Disease Control”.
Read Also: Buhari constitutes health reform panel, names Osinbajo chairman
The new NCDC DG obtained his medical degree at the University of Ilorin, Kwara State and trained in Paediatrics and Child Health at the Lagos University Teaching Hospital.
He also received the Fellowship of the West Africa College of Physicians in Paediatrics in 2005.
Adetifa studied Epidemiology at the University of Amsterdam, The Netherlands, where he bagged his MSC and PhD.
Until his appointment, Dr. Ifedayo Morayo Adetifa was an Associate Professor of Infectious Diseases Epidemiology at the London School of Hygiene and Tropical Medicine.
Adetifa’s research interests are in vaccine impact/effectiveness studies, innovative approaches/surveillance tools for monitoring vaccination, Tuberculosis Epidemiology, and evidence synthesis including systematic reviews.
In 2018 he was awarded the MRC/DFID African Research Leader Fellowship.
He is also a member of the Kenyan National Immunisation Coordinating Committee and a member of the World Health Organisation, Africa Region’s (WHO-AFRO) Regional Immunisation Technical Advisory Group.
He served overseas as a Clinical Epidemiologist at the KEMRI-Wellcome Trust Research Programme, Kiliufi, Kenya.
His vaccine policy advisory roles include membership of the Kenyan National Immunisation Coordination Committee, the WHO AFRO Regional Immunisation Technical Advisory Group (RITAG), the Advisory Group of the WHO Malaria Vaccine Implementation Programme, and the WHO Technical Advisory Group on RSV vaccines.
Discover more from LN247
Subscribe to get the latest posts sent to your email.
